An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer
An Open-label Randomized Trial of the Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy Alone for Advanced HER2-positive Biliary Tract Cancer
The purpose of this study is to evaluate the efficacy and safety of Zanidatamab plus CisGem (Cisplatin and Gemcitabine) with or without the addition of a programmed death protein 1/ligand-1 (PD-1/L1) inhibitor (physician's choice of either Durvalumab or Pembrolizumab, where approved under local regulations) as first line of treatment for participants with human epidermal growth factor receptor 2 (HER2)-positive biliary tract cancer.
Inclusion Criteria
Exclusion Criteria
ClinicalTrialDisclosure@JazzPharma.com215-832-3750
Duarte, California 91010, United States
Maple Grove, Minnesota 55369, United States
Morristown, New Jersey 07960, United States
New York, New York 10016, United States
Ciudad Autónoma de Buenos Aires (caba), Buenos Altes C1199ABB, Argentina
Viedma, Río Negro Province R8500ACE, Argentina
Rosario, Santa Fe Province S2013DTC, Argentina
San Miguel de Tucumán, Tucumán Province 4000, Argentina
San Miguel de Tucumán, Tucumán Province 4000, Argentina
Porto Alegre, Rio Grande do Sul 90035-903, Brazil
Porto Alegrev, Rio Grande do Sul 90020-170, Brazil
Jaú, São Paulo 17210-080, Brazil
São José do Rio Preto, São Paulo 15090-000, Brazil
Porto Alegre, 91350-200, Brazil
Toronto, Ontario M5G 2M9, Canada
Santiago, Santiago Metropolitan 7500859, Chile
Hefei, Anhui 230036, China
Hradec Králové, 50005, Czechia
Freiburg im Breisgau, Baden-Wurttemberg 79106, Germany
Heidelberg, Baden-Wurttemberg 69120, Germany
Tübingen, Baden-Wuttemberg 72076, Germany
München, Bavaria 81377, Germany
Frankfurt am Main, Hesse 60488, Germany
Hanover, Nieder-Sachsen 30625, Germany
Dresden, Saxony 01307, Germany
Lübeck, Schleswig-Holstein 23562, Germany
Berlin, 13353, Germany
Hamburg, 22763, Germany
Belagavi, Karnataka 590010, India
Nashik, Maharashtra 422005, India
Hyderabad, Telangana 500032, India
New Delhi, 110017, India
Monserrato, Cagliari 9042, Italy
Candiolo, Torino 10060, Italy
Udine, 33100, Italy
Osaka, Osaka 541-8567, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Chuo-Ku, Tokyo 104-0045, Japan
Koto-Ku, Tokyo 135-8550, Japan
Mitaka-shi, Tokyo 181-8611, Japan
Ube-Shi, Yamaguchi 755-8505, Japan
Suita-Shi, Ôsaka 565-0871, Japan
Almada, 2805-267, Portugal
Coimbra, 3004-561, Portugal
Lisbon, 1150-314, Portugal
Belgrade, 11000, Serbia
Belgrade, 11040, Serbia
Bundang-Gu, Seongnam-Si, Gyeonggi-do 13496, South Korea
Santiago de Compostela, A Coruna 15706, Spain
Barcelona, 8035, Spain
Gothenburg, 413 45, Sweden
Huddinge, 14186, Sweden
Kaohsiung City, 833, Taiwan
Taoyuan, 333, Taiwan
Istanbul, Fatih 34096, Turkey (Türkiye)
Surrey, England SM2 5PT, United Kingdom